在酒精相关的肝脏疾病和超越的IL-22疗法更新
Lihong Fu1, Burhan Yokus1, Bin Gao2
1Laboratory of Cardiovascular Physiology and Tissue Injury, NIH/National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
The American journal of pathology
|April 20, 2025
概括
干白素-22 (IL-22) 通过保护肝细胞和促进再生,在治疗与酒精有关的肝病 (ALD) 中表现有前途. 需要进一步的研究来优化IL-22治疗这种复杂的条件.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 过度饮酒会导致与酒精相关的肝病 (ALD),其特点是肝损伤和再生功能受损.
- 目前对ALD的治疗选择有限,需要新的治疗策略.
研究的目的:
- 审查INTERLEUKIN-22 (IL-22) 在ALD病变发生中的作用及其作为治疗点的潜力.
- 总结目前对IL-22生物学的理解,它对肝细胞的影响,以及它在治疗ALD和相关并发症中的应用.
主要方法:
- 关于IL-22和ALD的临床前模型和早期临床试验的文献评论.
- 分析IL-22的作用机制,包括STAT3通路激活,肝细胞存活率和肝脏再生.
主要成果:
- IL-22通过减少亡,氧化应激和炎症来表现出肝脏保护作用.
- 通过细胞增殖和生长因子上调调节,IL-22促进肝脏再生.
- 早期对IL-22激动剂 (F-652,UTTR1147A) 的研究表明,它们在减少肝损伤方面具有良好的安全性和有效性.
结论:
- 由于其多方面的保护性和再生性质,IL-22是ALD的有希望的治疗标.
- 优化基于IL-22的疗法需要进一步的研究,以解决ALD的异质性.
- 在酒精相关性肝病的综合管理策略中,IL-22可能发挥关键作用.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:24T Cell Types and Functions
617
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
617
01:27Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398
01:29Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97
01:29Chronic Pancreatitis II: Collaborative Care
48
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
48